Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005095464 | SCV002218255 | uncertain significance | not provided | 2022-03-08 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 207 of the B4GALT7 protein (p.Ser207Phe). This variant is present in population databases (rs774917613, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with B4GALT7-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). |
Fulgent Genetics, |
RCV002479555 | SCV002793928 | uncertain significance | Ehlers-Danlos syndrome, spondylodysplastic type, 1 | 2022-05-27 | criteria provided, single submitter | clinical testing |